Organon & Co. Announces CEO Resignation and Interim Appointments

TradingView
2025.10.27 11:45
portai
I'm PortAI, I can summarize articles.

On October 26, 2025, Organon & Co. announced the resignation of CEO Kevin Ali amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair, effective the same day. The reasons for Ali's resignation are linked to the ongoing investigation, while details regarding the replacements and committee role changes remain undisclosed.

On October 26, 2025, Organon & Co. announced the resignation of Kevin Ali as CEO and Board member amid an investigation. Joseph Morrissey has been appointed as Interim CEO, and Carrie S. Cox as Executive Chair.

IndividualKevin AliJoseph MorrisseyCarrie S. Cox
RoleCEO, Board MemberInterim CEOExecutive Chair
Type of ChangeResignedAppointedAppointed
Effective DateOct 26, 2025Oct 26, 2025Oct 26, 2025
ReasonInvestigationN/AN/A
Replacement InfoJoseph MorrisseyNot disclosedNot disclosed
Background DetailsN/AFormer EVP, Head of Manufacturing & SupplyN/A
Board/Committee Role ChangesNot disclosedNot disclosedNot disclosed

Original SEC Filing: Organon & Co. [ OGN ] - 8-K - Oct. 27, 2025

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.